Invesco Biotechnology & Genome ETF (PBE)
NYSEARCA: PBE · Real-Time Price · USD
65.54
+0.24 (0.37%)
At close: Aug 1, 2025, 4:00 PM
65.54
0.00 (0.00%)
After-hours: Aug 1, 2025, 8:00 PM EDT
PBE Holdings Information
PBE is an equity ETF with a total of 32 individual holdings. The top holdings are Illumina stock at 6.35%, Alnylam Pharmaceuticals at 5.75%, Royalty Pharma at 5.57%, Amgen at 5.29%, and Gilead Sciences at 5.16%.
Total Holdings
32
Top 10 Percentage
49.89%
Asset Class
Equity
ETF Category
Health
Assets
227.29M
PE Ratio
20.20
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | ILMN | Illumina, Inc. | 6.35% |
| 2 | ALNY | Alnylam Pharmaceuticals, Inc. | 5.75% |
| 3 | RPRX | Royalty Pharma plc | 5.57% |
| 4 | AMGN | Amgen Inc. | 5.29% |
| 5 | GILD | Gilead Sciences, Inc. | 5.16% |
| 6 | VRTX | Vertex Pharmaceuticals Incorporated | 5.16% |
| 7 | BMRN | BioMarin Pharmaceutical Inc. | 4.97% |
| 8 | UTHR | United Therapeutics Corporation | 4.40% |
| 9 | AVXL | Anavex Life Sciences Corp. | 4.06% |
| 10 | INCY | Incyte Corporation | 3.18% |
| 11 | PTGX | Protagonist Therapeutics, Inc. | 3.15% |
| 12 | QGEN | Qiagen N.V. | 3.09% |
| 13 | DVAX | Dynavax Technologies Corporation | 3.06% |
| 14 | NBIX | Neurocrine Biosciences, Inc. | 2.99% |
| 15 | HALO | Halozyme Therapeutics, Inc. | 2.96% |
| 16 | PTCT | PTC Therapeutics, Inc. | 2.85% |
| 17 | ACAD | ACADIA Pharmaceuticals Inc. | 2.84% |
| 18 | COLL | Collegium Pharmaceutical, Inc. | 2.79% |
| 19 | TGTX | TG Therapeutics, Inc. | 2.76% |
| 20 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.74% |
| 21 | RGEN | Repligen Corporation | 2.68% |
| 22 | FOLD | Amicus Therapeutics, Inc. | 2.63% |
| 23 | MNKD | MannKind Corporation | 2.46% |
| 24 | VCYT | Veracyte, Inc. | 2.29% |
| 25 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.29% |
As of Jul 30, 2025